Ignite Creation Date:
2024-05-06 @ 12:38 AM
Last Modification Date:
2024-10-26 @ 10:52 AM
Study NCT ID:
NCT01625234
Status:
COMPLETED
Last Update Posted:
2021-10-06
First Post:
2012-06-15
Brief Title:
Phase 12 Study of X-396 an Oral ALK Inhibitor in Patients With ALK-positive Non-Small Cell Lung Cancer
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06
Start Date Type:
None
Primary Completion Date:
2020-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-17
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-15
First Submit QC Date:
June 18 2012
Study First Post Date:
2012-06-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2021-09-13
Disp First Submit QC Date:
September 20 2021
Disp First Post Date:
2021-09-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-04
Last Update Post Date:
2021-10-06
Last Update Post Date Type:
ACTUAL